findmyKOL
Clinical trialNCT06616766RecruitingPhase 1, PHASE2Interventional

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

SponsorYuhan CorporationEnrollment161NSCLC (Non-small Cell Lung Cancer)Solid Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea

    Recruiting
  • the Catholic Univ. of Korea St. Vincent'S Hospital

    Suwon, Gyeonggi-do, South Korea

    Recruiting
  • Chungbuk National University Hospital

    Cheongju-si, North Chungcheong, South Korea

    Ki-Hyeong Lee
    Recruiting
  • Asan Medical Center, University of Ulsan

    Seoul, South Korea

    Sang-We Kim
    Recruiting
  • Samsung Medical Center

    Seoul, South Korea

    Recruiting
  • Seoul National University Hospital

    Seoul, South Korea

    Recruiting
  • Severance Hospital, Yonsei University

    Seoul, South Korea

    Recruiting
United States
  • Next Oncology Virginia

    Fairfax, Virginia, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Oct 2024
Primary completion
15 Mar 2028
Completion
29 Jul 2028
Last update posted
4 Nov 2025
Registered enrollment
161
Registry id
NCT06616766
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.